HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
News & Information

News & Information

IAC
EXPRESS
Stay current! Every week, IAC Express features important immunization developments delivered directly to your email box.
Read Latest Issue
Subscribe Today - it's free!
Official Releases
The latest vaccine licensures, recommendations and resources from official sources
  Advisory Committee on Immunization Practices
  Centers for Disease Control and Prevention
  Food and Drug Administration
>> View All
 
What's New at IAC
Chronological listing of new and revised IAC materials
Handouts
VISs
Web Pages
>> View All
 
Coronavirus (COVID-19) Information from IAC
Featured Resources
BREAKING NEWS
10/15/2021
Updated Vaccine Information Statements (VIS) for Hepatitis A, Hepatitis B, and Rotavirus vaccines have been posted. Also, an updated version of the multiple pediatric vaccine VIS, "Your Child's First Vaccines: What You Need to Know"
10/14/2021
FDA approves expanded age indication for Flucelvax Quadrivalent (Seqirus Inc), now licensed for persons 6 months of age and older
9/22/2021
FDA authorizes booster dose of Pfizer-BioNTech COVID-19 Vaccine for aged 65 years and older, aged 18 through 64 at high risk of severe COVID-19, aged 18 through 64 who have institutional or occupational exposure to SARS-CoV-2
8/27/21
Just released! ACIP Recommendations for the Prevention and Control of Seasonal Influenza with Vaccines — US, 2021–22 Influenza Season
8/23/21
FDA approves COVID-19 vaccine Comirnaty (Pfizer-BioNTech) for individuals 16 and older. The EUA remains in effect for individuals 12 years of age and older and for the third dose for immunocompromised individuals 12 years of age and older.
8/13/21
FDA approves Ticovac (Pfizer) a vaccine to prevent tick-borne encephalitis (TBE) vaccine in individuals 1 year of age and older.
8/12/21
FDA amends the emergency use authorizations (EUAs) for Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals
8/6/21
Updated Vaccine Information Statements (VIS) for DTaP, Hib, HPV, live attenuated influenza, inactivated influenza, MMR, MMRV, MenACWY, MenB, PCV13, Polio, Tdap, Td, and VAR have been posted
7/16/21
FDA approves Vaxneuvance (Merck & Co, Inc.) pneumococcal 15-valent conjugate vaccine for adults 18 years or older
6/9/21
FDA approves Prevnar 20 (Pfizer) pneumococcal 20-valent conjugate vaccine for adults 18 years or older
5/14/21
Just released! ACIP Interim Recommendations for use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 years, US, May 2021
5/10/21
FDA expands the emergency use authorization of Pfizer-BioNTech COVID-19 vaccine to include adolescents 12–15 years of age
4/27/21
Just released MMWR! Updated Recommendation from ACIP for Use of Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — U.S., April 2021
4/23/21
CDC and FDA lift recommended pause of use of Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. after a review by ACIP. Use of vaccine should resume. EUA fact sheets for Johnson & Johnson (Janssen) COVID-19 Vaccine revised.
4/13/21
CDC and FDA recommended a pause in use of the Janssen (Johnson & Johnson) COVID-19 vaccine in the United States out of an abundance of caution. ACIP to hold emergency meetings. A CDC Health Alert Network (HAN) was issued with recommendations.
3/2/21
Just released! ACIP Interim Recommendation for Use of Janssen (Johnson and Johnson) COVID-19 Vaccine – U.S., February 2021
2/27/21
FDA issues emergency use authorization (EUA) for third COVID-19 vaccine. The EUA allows the single dose Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
2/12/21
Just released in MMWR! 2021 U.S. Recommended Immunization Schedules for Children and Adolescents Age 18 Years or Younger
2/12/21
Just released in MMWR! 2021 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
12/22/20
Just released! ACIP Updated Interim Recommendation for Allocation of COVID-19 Vaccine – U.S., December 2020
12/20/20
Just released! ACIP Interim Recommendation for Use of Moderna COVID-19 Vaccine – U.S, December 2020
12/13/20
Just released! ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – U.S., December 2020
12/11/20
FDA issues Emergency Use Authorization (EUA) for first COVID-19 vaccine (Pfizer-BioNTech COVID-19)
12/3/20
Just released! ACIP Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine – U.S., 2020
9/25/20
Just released! Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
8/21/20
Just released! ACIP Recommendations for the Prevention and Control of Seasonal Influenza with Vaccines — US, 2020–21 Influenza Season
7/28/20
Updated Vaccine Information Statement for hepatitis A is posted
7/3/20
Just released! Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
4/1/20
Updated Vaccine Information Statements for DTaP (diphtheria, tetanus and pertussis), Td (tetanus, diphtheria), Tdap (tetanus, diphtheria, and pertussis), yellow fever, and Multi-Vaccines have been posted
2/7/20
Just released in MMWR! 2020 U.S. Recommended Immunization Schedules for Children and Adolescents Age 18 Years or Younger
2/7/20
Just released in MMWR! 2020 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older in MMWR
2/7/20
Just released! Guidance for the use of Vaxelis a DTaP, IPV, Hib, and HepB combination vaccine for infants (the manufacturer, MCM Vaccine Co., has stated that vaccine will not be commercially available in the U.S. before 2021)
2/3/20
CDC releases "Recommended Child and Adolescent Immunization Schedule" for 2020
2/3/20
CDC releases "Recommended Adult Immunization Schedule" for 2020
Calendar of events: conferences and meetings on immunization
 
This page was updated on October 20, 2021.
This page was reviewed on January 29, 2021.
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Storage & Handling
Vaccination and COVID-19
Vaccine Recommendations
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
Vaccines: COVID-19
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IAC EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Q&As: Easy-to-Read
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IAC EXPRESS
Subscribe to IAC Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
SLIDE SETS
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IAC EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
(ARCHIVE)
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
COVID-19
Hepatitis B
HPV (Human papillomavirus)
Influenza
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 1NH23IP922654) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.